The global stent graft balloon catheter market was valued at approximately USD 915.92 million in 2022, representing around 3.5% of the overall catheter market. Looking ahead, sales of stent graft balloon catheters are anticipated to experience robust growth, with a projected compound annual growth rate (CAGR) of 7%. By 2032, the market is expected to reach a valuation of approximately USD 1,801.75 million.
The growth of the stent graft balloon catheter market is primarily driven by the increasing prevalence of cardiovascular diseases and the rising number of minimally invasive surgical procedures. These catheters play a crucial role in a range of cardiovascular interventions, including the treatment of aneurysms and vascular obstructions, thereby enhancing patient outcomes.
As healthcare providers continue to focus on innovative treatment options and patient-centered care, the demand for stent graft balloon catheters is expected to rise significantly. Additionally, ongoing advancements in catheter technology and design will likely contribute to the market’s growth, offering improved performance and safety for patients.
The key drivers of the stent graft balloon catheter market include the following:
- Increasing prevalence of Coronary Artery Diseases (CADs)
- Rising number of atherosclerosis patients worldwide
- Increased healthcare spending and improvement in healthcare infrastructure in emerging countries
The key reasons driving the growth of the stent graft balloon catheter market are rising heart disorders and an ageing population. Furthermore, the rising frequency of peripheral vascular disorders, together with developments in catheterization technology, are expected to drive market expansion.
Furthermore, government and non-government organisations’ initiatives to raise awareness about cardiovascular illnesses are expected to drive the stent graft balloon catheter market growth over the forecast period. For example, the National Heart, Lung, and Blood Institute, along with other organisations throughout the United States, observes National Red Day each year to promote awareness about heart problems. Such measures help to drive market expansion in developed countries.
The exorbitant cost of angioplasty treatments, however, and a scarcity of competent doctors are impeding the stent graft balloon catheter market expansion.
Stent Graft Balloon Catheter Market: Key Players
Some of the key market players in stent graft balloon catheter market includes Medtronic, Boston Scientific, Abbott Laboratories, Cordis, Atrium Medical, W. L. Gore & Associates Inc., JOTEC GmbH, QXMédical, LLC etc. these players are entering into mergers & acquisitions, strategic collaborations, and product portfolio expansions, distribution agreements which are their key sustainability strategies. Secondly many local players have started entering in this lucrative market.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
Stent Graft Balloon Catheter Market: Segmentation
This market is segmented on the basis of product type and end user
Segmentation based by product type:
- Non Complaint Balloon Stents Catheter
- Complaint Balloon Stents Catheter
Segmentation based by end user:
- Hospitals
- Cardiac Centers
- ASCs
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
